recent
nosocomi
transmiss
event
emerg
reemerg
virus
includ
ebola
viru
middl
east
respiratori
syndrom
coronaviru
nipah
viru
crimeancongo
hemorrhag
fever
orthonairoviru
highlight
risk
nosocomi
transmiss
emerg
virus
healthcar
set
particular
concern
precaut
increas
regard
use
aerosolgener
medic
procedur
treat
patient
viral
infect
spite
increas
associ
aerosolgener
medic
procedur
nosocomi
transmiss
virus
still
poor
understand
risk
specif
procedur
virus
order
identifi
aerosolgener
medic
procedur
emerg
virus
pose
high
risk
healthcar
worker
explor
mechan
aerosolgener
medic
procedur
well
transmiss
pathway
characterist
highli
pathogen
virus
associ
nosocomi
transmiss
propos
research
clinic
experiment
set
could
advanc
current
infect
control
guidelin
aerosolgener
medic
procedur
agmp
increasingli
recogn
import
sourc
nosocomi
transmiss
emerg
virus
intub
investig
possibl
caus
ebola
viru
ebov
transmiss
among
healthcar
worker
hcw
unit
state
addit
high
rate
nosocomi
transmiss
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
specul
role
agmp
crimeancongo
hemorrhag
fever
orthonairoviru
cchfv
also
associ
nosocomi
infect
secondari
agmp
guidelin
develop
perform
agmp
patient
certain
viral
infect
assess
understand
risk
specif
virus
agmp
pose
nosocomi
transmiss
could
improv
infect
control
practic
well
reveal
relationship
viru
transmiss
despit
perceiv
import
agmp
nosocomi
transmiss
virus
infecti
agent
scarc
empir
quantit
evid
exist
order
assess
risk
certain
virus
agmp
creat
nosocomi
transmiss
first
need
identifi
potenti
agmp
virus
second
step
determin
risk
associ
virus
procedur
either
retrospect
analysi
investig
circumst
nosocomi
transmiss
experi
use
air
sampl
agmp
determin
risk
gener
infecti
virusladen
aerosol
lastli
use
knowledg
transmiss
laser
creat
plume
debri
contain
infecti
aerosol
viru
well
import
recogn
rang
agmp
circumst
might
perform
infect
patient
order
associ
certain
agmp
nosocomi
viru
transmiss
research
need
test
whether
certain
procedur
gener
aerosol
infecti
viru
either
hospit
sampl
laboratori
procedur
figur
potenti
type
aerosolgener
medic
procedur
agmp
agmp
divid
procedur
induc
patient
produc
aerosol
procedur
mechan
gener
aerosol
know
mechan
behind
differ
agmp
allow
us
narrow
focu
emerg
virus
could
caus
nosocomi
transmiss
via
agmp
virus
must
abl
figur
potenti
type
aerosolgener
medic
procedur
agmp
agmp
divid
procedur
induc
patient
produc
aerosol
procedur
mechan
gener
aerosol
contrast
caus
patient
produc
aerosol
agmp
also
mechan
creat
dispers
respiratori
aerosol
procedur
ventil
suction
airway
nebul
treatment
manual
ventil
use
bagvalvemask
form
noninvas
ventil
niv
continu
posit
airway
pressur
cpap
bilevel
posit
airway
pressur
bipap
highfrequ
oscillatori
ventil
hfov
associ
sarscov
nosocomi
transmiss
although
exact
mechan
procedur
creat
virusladen
aerosol
respiratori
tract
remain
unknown
possibl
forc
remov
air
respiratori
tract
could
gener
aerosol
agmp
tradit
thought
regard
gener
respiratori
aerosol
agmp
also
aerosol
infect
fluid
region
human
bodi
surgic
techniqu
aerosol
blood
possibl
virus
exampl
infecti
found
aerosol
gener
surgic
power
tool
tracheotomi
associ
sarscov
transmiss
laser
creat
plume
debri
contain
infecti
aerosol
viru
well
import
recogn
rang
agmp
circumst
might
perform
infect
patient
order
associ
certain
agmp
nosocomi
viru
transmiss
research
need
test
whether
certain
procedur
gener
aerosol
infecti
viru
either
hospit
sampl
laboratori
procedur
know
mechan
behind
differ
agmp
allow
us
narrow
focu
emerg
virus
could
caus
nosocomi
transmiss
via
agmp
virus
must
abl
opportunist
infect
via
aerosol
rout
must
present
patient
agmp
take
place
two
condit
fit
wide
spectrum
virus
therefor
focu
emerg
pose
high
risk
hcw
perform
agmp
defin
high
risk
high
likelihood
infect
aerosol
inhal
come
contact
mucou
membran
high
casefat
rate
viral
diseas
virus
highli
infecti
pathogen
limit
prophylact
therapeut
countermeasur
avail
includ
biosafeti
level
virus
exclud
virus
measl
mump
rubella
infect
via
aerosol
rout
spread
agmp
common
vaccin
protect
hcw
virus
norwalk
viru
enterovirus
human
respiratori
syncyti
viru
rsv
either
caus
selflimit
diseas
primarili
pathogen
pediatr
pregnant
immunocompromis
patient
also
includ
infect
control
measur
must
perform
virus
patient
hospit
visitor
also
risk
nosocomi
viru
transmiss
howev
focu
novel
highrisk
virus
hcw
perform
agmp
consid
emerg
highli
pathogen
virus
use
follow
criteria
assess
virus
high
risk
hcw
perform
agmp
viru
infecti
via
small
larg
droplet
aerosol
human
nonhuman
primat
nhp
although
virusladen
aerosol
specif
larg
droplet
could
land
surfac
caus
subsequ
fomit
transmiss
infect
via
inhal
aerosol
aerosol
contact
eye
mucou
membran
may
potenti
caus
nosocomi
transmiss
agmp
viru
found
human
respiratori
tract
respiratori
tract
nhp
agmp
occur
upper
lower
human
respiratori
tract
therefor
viru
present
locat
expect
higher
likelihood
becom
aerosol
previou
evid
nosocomi
transmiss
associ
agmp
third
criteria
identifi
virus
associ
type
transmiss
past
although
may
miss
virus
emerg
frequent
infect
human
virus
pose
highest
risk
hcw
perform
agmp
may
virus
know
least
mani
virus
may
emerg
zoonot
virus
rare
infect
human
compar
humanadapt
virus
therefor
reli
knowledg
human
anim
viral
infect
creat
list
potenti
virus
tabl
includ
virus
fit
least
two
three
previous
mention
classif
mani
virus
also
world
health
organ
list
prioriti
pathogen
research
develop
prepared
virus
identifi
high
risk
come
eight
famili
divers
characterist
howev
also
much
common
virus
emerg
reemerg
zoonot
rna
virus
initi
spill
anim
host
human
virus
undergo
subsequ
humantohuman
nosocomi
transmiss
caus
epidem
howev
unlik
virus
evolv
human
host
none
virus
endem
human
popul
virus
may
caus
stutter
chain
transmiss
disappear
human
popul
other
like
ebola
viru
pandem
influenza
viru
may
caus
larg
outbreak
contain
establish
endem
pathogen
human
popul
virus
evolv
within
host
maintain
optimum
balanc
transmiss
consequ
virul
persist
human
reservoir
host
virus
equilibrium
establish
highrisk
virus
highli
infecti
virul
effici
transmit
persist
true
human
respiratori
virus
highrisk
virus
belong
famili
coronavirus
orthomyxovirus
paramyxovirus
come
closest
equilibrium
persist
transmiss
human
uncoincident
viral
famili
also
contain
virus
becom
endem
human
popul
ii
laboratori
worker
infect
inhal
aerosol
upper
respiratori
viral
rna
nhp
oral
nasal
swab
ii
viru
isol
human
throat
swab
ii
iii
nosocomi
transmiss
lower
respiratori
ii
viru
isol
human
lung
hantavirida
nairovirida
phenuivirida
cchf
viru
ii
hantavirus
iii
rift
valley
fever
viru
ii
iii
laboratori
worker
infect
inhal
aerosol
upper
respiratori
iii
viral
rna
nhp
nasal
swab
iii
viral
rna
nhp
oral
swab
ii
viral
rna
human
saliva
lower
respiratori
ii
nosocomi
transmiss
like
associ
agmp
ii
caus
human
respiratori
diseas
viral
antigen
human
lung
coronavirida
merscov
ii
sarscov
ii
laboratori
healthcar
worker
infect
inhal
aerosol
ii
known
humantohuman
aerosol
transmiss
upper
respiratori
ii
viral
rna
nasalthroat
swab
ii
nosocomi
transmiss
ii
signific
associ
agmp
lower
respiratori
ii
caus
human
respiratori
diseas
viru
isol
lung
sputum
filovirida
ebolavirus
ii
marburg
viru
ii
nhp
infect
aerosol
administr
upper
respiratori
isol
human
saliva
ii
isol
nhp
saliva
upper
respiratori
ii
isol
human
nasal
throat
secret
ii
nosocomi
transmiss
lower
respiratori
ii
caus
human
respiratori
diseasei
viral
antigen
human
lung
consid
eight
viral
famili
begin
assess
risk
particular
virus
make
conclus
risk
assess
need
experiment
epidemiolog
evid
inform
futur
studi
first
look
current
known
virus
famili
regard
agmp
famili
arenavirida
order
bunyaviral
contain
multipl
virus
potenti
nosocomi
transmiss
due
agmp
arenavirus
spill
human
inhal
aerosol
excreta
rodent
host
virus
addit
laboratori
worker
nhp
also
infect
aerosol
arenavirus
specif
junin
viru
lassa
viru
machupo
viru
arenaviru
infect
caus
viral
hemorrhag
fever
vhf
human
known
nosocomi
transmiss
occur
patient
infect
lassa
viru
machupo
viru
less
clinic
experiment
data
exist
arenavirus
may
similar
characterist
although
arenavirus
found
respiratori
tract
human
anim
model
evid
humantohuman
airborn
transmiss
arenavirus
howev
arenaviru
aerosol
transmiss
could
theoret
occur
aerosol
mechan
gener
agmp
like
arenavirus
multipl
virus
within
order
bunyaviral
zoonot
caus
vhf
crimeancongo
hemorrhag
fever
cchf
orthonairoviru
and
hantaviru
associ
nosocomi
transmiss
cchf
transmiss
occur
agmp
perform
without
eye
respiratori
protect
interestingli
hantavirus
aerosol
transmit
human
either
accident
aerosol
viru
inhal
aerosol
rodent
excreta
and
hantaviru
confirm
transmit
person
person
although
hantavirus
caus
respiratori
diseas
human
hantaviru
pulmonari
syndrom
hp
found
respiratori
tract
seem
effici
transmit
human
like
typic
respiratori
virus
howev
similar
arenavirus
certain
bunyavirus
found
humanor
animalmodel
respiratori
tract
includ
cchf
viru
hantavirus
rift
valley
fever
viru
could
possibl
gain
rout
aerosol
transmiss
agmp
perform
famili
coronavirida
contain
virus
known
transmit
routin
human
aerosol
rout
merscov
sarscov
caus
respiratori
diseas
human
transmit
via
aerosol
unknown
whether
smalldroplet
largedroplet
aerosol
mode
transmiss
virus
signific
nosocomi
transmiss
sarscov
incit
research
regard
role
agmp
nosocomi
viru
transmiss
recent
nosocomi
transmiss
event
merscov
warrant
research
therefor
agmp
could
possibl
amplifi
alreadi
establish
rout
infect
virus
filovirus
also
caus
vhf
could
potenti
becom
transmiss
agmp
outbreak
ebola
viru
diseas
evd
concern
rais
regard
airborn
transmiss
ebov
nosocomi
transmiss
event
discoveri
viru
human
respiratori
tract
given
know
experiment
epidemiolog
evid
airborn
transmiss
unlik
yet
possibl
agmp
could
creat
infecti
ebovladen
aerosol
could
lead
nosocomi
transmiss
likewis
virus
belong
speci
ebolavirus
pathogen
human
well
anoth
filoviru
marburg
viru
could
share
similar
transmiss
properti
famili
virus
orthomyxovirida
contain
human
zoonot
virus
wellknown
influenza
virus
season
flu
vaccin
protect
hcw
influenza
howev
variat
effici
humantohuman
aerosol
transmiss
differ
influenza
virus
instanc
date
instanc
nosocomi
transmiss
even
protect
measur
use
multipl
nosocomi
transmiss
event
pandem
influenza
viru
subtyp
could
due
variat
infect
viru
tissu
tropism
pandem
preferenti
replic
human
upper
respiratori
tract
avian
influenza
virus
preferenti
replic
lower
respiratori
tract
therefor
agmp
potenti
amplifi
open
rout
aerosol
transmiss
influenza
virus
understand
characterist
aerosol
transmiss
differ
influenza
virus
subtyp
could
help
us
determin
risk
influenza
virus
nosocomi
transmiss
due
agmp
virus
famili
paramyxovirida
recent
emerg
nipah
hendra
virus
pose
high
risk
hcw
perform
agmp
virus
known
caus
respiratori
diseas
human
nosocomi
transmiss
document
nipah
viru
aerosol
transmiss
one
suspect
rout
transmiss
nipah
viru
evid
contact
trace
find
viru
human
respiratori
secret
hendra
viru
spill
hors
human
humantohuman
transmiss
document
viru
detect
human
lung
although
henipavirus
seem
contagi
aerosol
rout
peopl
virus
famili
measl
viru
possibl
agmp
could
contribut
format
infecti
nipahand
hendraladen
aerosol
could
caus
nosocomi
infect
given
lack
experiment
epidemiolog
data
nosocomi
viru
transmiss
agmp
current
guidelin
infect
control
base
precautionari
principl
order
nuanc
understand
risk
associ
differ
agmp
virus
need
research
clinic
experiment
set
type
research
could
take
two
differ
form
retrospect
epidemiolog
studi
onsit
sampl
experiment
test
former
use
assess
risk
agmp
sarscov
transmiss
howev
qualiti
retrospect
data
limit
kind
studi
control
case
necessari
rule
sourc
nosocomi
transmiss
besid
agmp
direct
patient
contact
fomit
transmiss
moreov
studi
reli
report
may
infrequ
andor
unreli
air
sampl
virus
agmp
perform
patient
would
provid
clinic
relev
data
multipl
airsampl
techniqu
virus
exist
research
use
solid
liquid
impactor
sampl
recov
aerosol
virus
person
worn
bioaeros
sampler
stationari
room
sampler
use
detect
influenza
viru
rna
emerg
depart
research
also
use
aerosol
sampler
determin
amount
influenza
rna
aerosol
vicin
patient
agmp
perform
allow
author
determin
procedur
associ
higher
concentr
viral
rna
order
determin
whether
viabl
viru
present
aerosol
viru
isol
could
perform
air
sampl
quantif
could
occur
titrat
plaqu
assay
one
group
use
simul
aerosol
chamber
demonstr
viabl
influenza
viru
could
extract
surgic
mask
respir
particl
sizer
may
also
use
experiment
set
character
size
dispers
aerosol
one
group
use
particl
sizer
measur
size
travel
distanc
aerosol
patient
underw
agmp
nebul
treatment
niv
determin
quantiti
viabl
viru
expel
certain
patient
agmp
could
help
determin
phenomena
like
superspread
event
understand
aerosol
characterist
particl
size
could
elucid
mechan
transmiss
onsit
sampl
work
current
nosocomi
transmiss
event
design
experi
gain
prospect
knowledg
procedur
bronchoscopi
intub
perform
anim
model
highrisk
viral
diseas
identifi
air
sampl
procedur
could
determin
whether
aerosolgener
experiment
gener
virusladen
aerosol
differ
size
differ
environment
condit
could
also
help
determin
risk
differ
virus
base
stabil
aerosol
research
could
creat
risk
model
differ
virus
base
aersol
stabil
well
data
quantiti
concentr
travel
distanc
size
aerosol
form
agmp
multipl
environment
factor
influenc
viabil
aerosol
virus
includ
rel
humid
temperatur
uv
radiat
ga
composit
air
factor
affect
virus
differ
import
consid
environ
emerg
virus
exist
agmp
perform
aforement
agmp
includ
ubiquit
cpr
manual
ventil
well
limit
advanc
healthcar
set
bronchoscopi
risk
transmiss
agmp
may
differ
fieldbas
treatment
unit
tertiari
care
hospit
addit
healthcar
set
hospit
biocontain
unit
includ
addit
airhandl
system
limit
aerosol
exposur
hcw
therefor
risk
nosocomi
transmiss
via
agmp
vari
greatli
base
environ
must
consid
design
experi
outbreak
evd
center
diseas
control
prevent
cdc
updat
guidelin
regard
precaut
prevent
transmiss
ebov
healthcar
set
updat
guidelin
emphas
proper
person
protect
equip
ppe
isol
perform
agmp
evd
patient
current
addit
standard
ppe
cdc
recommend
use
eye
protect
airborn
infect
isol
room
higher
respir
perform
agmp
patient
vhf
sarscov
avian
pandem
influenza
virus
cdc
made
similar
recommend
interim
guidanc
merscov
unabl
find
addit
cdc
agmp
guidelin
nipah
viru
hendra
viru
hantavirus
evid
nosocomi
transmiss
event
virus
due
agmp
like
prompt
futur
guidelin
therefor
understand
risk
associ
agmp
nosocomi
viru
transmiss
static
must
continu
improv
knowledg
develop
appropri
precaut
ambigu
procedur
virus
requir
addit
protect
measur
agmp
may
lead
breach
protocol
mani
cite
nosocomi
transmiss
event
hcw
use
proper
eye
respiratori
protect
even
awar
need
respiratori
protect
hcw
may
mistakenli
wear
surgic
mask
unfit
respir
provid
proper
protect
addit
hcw
may
access
approprti
ppe
depend
healthcar
environ
therefor
determin
risk
certain
virus
procedur
essenti
commun
respect
precaut
provid
resourc
equal
import
likewis
proper
patient
triag
diagnosi
first
step
ensur
precaut
undertaken
perform
agmp
overal
research
commun
risk
certain
virus
agmp
necessari
resolv
uncertainti
surround
role
nosocomi
viru
transmiss
although
identifi
certain
virus
procedur
could
high
risk
experiment
clinic
test
emerg
virus
novel
procedur
may
also
play
signific
role
design
proactiv
infect
control
guidelin
understand
underli
biolog
viral
transmiss
must
conduct
collabor
clinic
scientif
research
nosocomi
viru
transmiss
agmp
